| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.39B | 70.91B | 63.72B | 58.74B | 54.56B | 46.74B |
| Gross Profit | 14.29B | 15.32B | 14.04B | 13.76B | 13.30B | 11.30B |
| EBITDA | 10.60B | 11.46B | 10.74B | 11.10B | 10.19B | 8.65B |
| Net Income | 5.10B | 5.92B | 4.87B | 5.79B | 5.32B | 4.36B |
Balance Sheet | ||||||
| Total Assets | 75.49B | 82.24B | 71.59B | 67.84B | 60.27B | 54.03B |
| Cash, Cash Equivalents and Short-Term Investments | 24.72B | 28.07B | 23.41B | 22.79B | 21.67B | 18.24B |
| Total Debt | 4.69B | 6.17B | 321.46M | 381.21M | 469.07M | 1.37B |
| Total Liabilities | 26.68B | 29.76B | 21.95B | 20.61B | 18.46B | 17.46B |
| Stockholders Equity | 45.43B | 48.64B | 46.29B | 44.30B | 39.33B | 34.52B |
Cash Flow | ||||||
| Free Cash Flow | 623.18M | 4.11B | 4.40B | 2.74B | 5.43B | 2.71B |
| Operating Cash Flow | 1.87B | 10.47B | 7.84B | 5.88B | 7.89B | 6.61B |
| Investing Cash Flow | -1.58B | -6.91B | -3.87B | -2.61B | -2.64B | -4.35B |
| Financing Cash Flow | -472.80M | 776.26M | -3.20B | -2.38B | -2.15B | -763.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥54.58B | 13.85 | ― | 3.33% | 7.46% | 18.73% | |
71 Outperform | ¥83.17B | 14.29 | 11.16% | 3.41% | 11.29% | 22.71% | |
71 Outperform | ¥305.16B | 13.79 | 30.73% | 2.20% | 5.71% | -51.99% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥34.19B | 18.14 | ― | 2.59% | 0.68% | 33.74% | |
60 Neutral | ¥65.28B | 10.29 | ― | 2.18% | 6.54% | 140.15% | |
54 Neutral | ¥16.69B | 30.45 | ― | 1.13% | 3.36% | -15.06% |